Cipla Limited (NSE:CIPLA)
India
· Delayed Price · Currency is INR 1,319.00
+12.50 (0.96%)
Apr 29, 2026, 2:30 PM IST
Cipla Employees
Cipla had 30,313 employees as of March 31, 2025. The number of employees increased by 2,549 or 9.18% compared to the previous year.
Employees
30,313
Change (1Y)
2,549
Growth (1Y)
9.18%
Revenue / Employee
9.23M INR
Profits / Employee
1.50M INR
Market Cap
1,055.37B
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| Mankind Pharma | 19,620 |
| Zydus Lifesciences | 27,917 |
| Aurobindo Pharma | 27,707 |
| Glenmark Pharmaceuticals | 15,800 |
| Divi's Laboratories | 10,542 |
| Alkem Laboratories | 18,785 |
| Laurus Labs | 6,167 |
| Ipca Laboratories | 16,778 |
Cipla News
- 2 days ago - Cohance Lifesciences Hits 20% Upper Circuit After Appointing Former Cipla CEO Umang Vohra as Chairman and Group CEO - Business Upturn
- 5 days ago - Cipla faces $100 million revenue risk as USFDA alert delays restart beyond FY27, says Macquarie - Business Upturn
- 5 days ago - Cipla Shares Fall 3% as Partner Unit Gets FDA Import Alert, Lanreotide Revenue at Risk - Business Upturn
- 5 days ago - Broker Calls Today: Infosys Gets Mixed Bag, Dr Reddy's Downgraded, Cipla Bullish on Ventolin Approval — Full Analyst Roundup - Business Upturn
- 5 days ago - Nifty 50 top gainers today, April 23: Dr. Reddy's Laboratories, Cipla, Jio Financial Services, Adani Enterprises and more - Business Upturn
- 6 days ago - Cipla gets USFDA nod for first AB-rated generic of Ventolin HFA - Business Upturn
- 6 days ago - Cipla receives USFDA approval for first AB-rated generic of Ventolin HFA - Business Upturn
- 7 days ago - Pharma sector stocks today, April 22: Natco Pharma up 1.4%, Lupin falls 1.01%, Cipla down 0.73% - Business Upturn